Second, association between HER2 RNA levels and Ki67 in MutL− ER+/HER2− breast tumors is only significant after exposure to endocrine treatment and not in pre-treatment biopsies (Fig. S7D). This evidence concerns the gene ERBB2 and breast neoplasm.